Pfizer Dodges More Sanctions In Neurontin Antitrust MDL
A magistrate judge refused Tuesday to sanction Pfizer Inc. by striking its denial that it promoted off-label uses of epilepsy drug Neurontin, the latest in a New Jersey multidistrict litigation claiming...To view the full article, register now.
Already a subscriber? Click here to view full article